Cerebrospinal Fluid Management Market Scope, Analysis, and Trends by 2030
Cerebrospinal Fluid Management Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 1.91 Billion |
| Market Size by 2030 | US$ 2.89 Billion |
| Global CAGR (2022 - 2030) | 5.3% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2030 |
| Segments Covered |
By Product
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
COVID-19 Impact:
During the pre-COVID-19 pandemic era, the treatment procedures for CSF leaks had a substantial number. For instance, in the US, CSF diversion procedures held 29% of the 843 surgeries in the neurology department from March 2019 to February 2020. The number of CSF diversion procedures significantly contributed to the market growth. Also, the demand and supply for CSF shunts and drainage systems were met efficiently. During the pandemic, the supply chain was disrupted, restricting healthcare facilities for several health conditions, including neurological diseases. The pandemic span adversely affected the market and shifted the focus of medical device companies toward the in-vitro diagnostics of COVID-19. The market was expanded for the point of care diagnostics, resulting in negative outcomes for the cerebrospinal fluid management market.
On the other hand, during the post-COVID-19 pandemic scenario, there was an exponential rise in the CSF shunt and CSF drainage procedures as acute COVID-19 infection was reported to show a direct or indirect connection to the nervous system in the many numbers of COVID-19-positive cases. However, there is limited information about the CSF outcomes with COVID-19 available that leveraged the opportunities for research and development. Post-pandemic, the awareness of the CSF shunt procedures was increased, which leveraged the market growth significantly and is expected to show a similar trend in the coming years. Product development has been increased by incorporating digital technologies to monitor and control cerebrospinal fluid flow in patients. Thus, technological advancements are contributing significantly to the growth of the market.
Competitive Landscape and Key Companies:
A few prominent players operating in the cerebrospinal fluid management market are Medtronic Plc, Integra LifeSciences Holdings Corp, B. Braun SE, Argi Group Health Services Ltd Sti, Sophysa SA, BeckerSmith Medical Inc, Delta Surgical Ltd, Moller Medical GmbH, Natus Medical Inc, and Spiegelberg GmbH & Co KG. These companies focus on new product launches and geographic expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. Their global presence allows them to serve a large set of customers, subsequently allowing them to expand their market share.
Get Free Sample For